Explore the opportunities and challenges of genomics in this 51-minute panel discussion from the RSA Conference. Gain insights from industry leaders as they delve into precision medicine, consumer privacy protection, security risks, and potential biases in genomic data. Learn about the role of companies like 23andMe and healthcare providers in advancing genomic research while addressing ethical concerns. Discover how genomics is revolutionizing healthcare and personal health management, and understand the implications of data breaches in this sensitive field. Engage with expert perspectives on data de-identification, monetization of genomic information, and the future of personalized medicine.